15. PROGNOSING VALIDITY OF BIOLOGICAL CHARACTERISTICS OF COVID-19 PATIENTS AT THU DUC CITY HOSPITAL

Nguyen Thi Bich Uyen1, Phu Chi Dung2
1 Thu Duc Hospital
2 Blood Transfusion Hematology Hospital

Main Article Content

Abstract

Objectives: To determine the change of biological indicators in patients with COVID-19 according to the hospital stay and the mortality prognostic value.


Methods: Retrospective study, monitoring medical records at Thu Duc City Hospital, Ho Chi Minh City from June 2021 to December 2021 on 269 inpatient COVID-19 patients. Record the indicators of blood cell analysis, liver and kidney function and blood coagulation of the patient in days 1, 3, 5 and the last day.


Results: A decrease in platelet count and an increase in white blood cell count on the last day of follow-up, there was a difference between the mortality and survival groups. An increase in AST and ALT from 28 to nearly 60 U/L on the last day indicated liver failure, and Creatinine in the mortality group increased to 1.77 mg/dl indicating renal failure. Logistic regression analysis recorded the prognostic factors of death in patients with COVID-19 including: increase in D-Dimer, increase in neutrophils, decrease in lymphocytes and decrease in hemoglobin (p<0.05). In which, D-Dimer > 1,126 ng/mL is the optimal cut-off value with accuracy: 66%, sensitivity: 90.57%, specificity: 60.19% and AUC=0.809; neutrophil count >6,715 x109/L has accuracy: 70.26%, sensitivity: 52.83%, specificity: 82.87% and AUC=0.726. Lymphocytes and hemoglobin both have low AUCs.


Conclusion: Biological indicators have daily changes and good prognosis of mortality risk in patients.

Article Details

References

[1] Tang N, Li, et al., “Abnormal coagulation
parameters are associated with poor prognosis in
patients with novel coronavirus pneumonia”; J
Thromb Haemost, 18 (4), 2020, 844-847.
[2] Wang D, Hu, et al., “Clinical Characteristics
of 138 Hospitalized Patients With 2019 Novel
Coronavirus-Infected Pneumonia in Wuhan,
China”. JAMA, 323 (11), 2020, 1061-1069.
[3] Soni M, Gopalakrishnan, et al., “D-dimer level
is a useful predictor for mortality in patients with
COVID-19: Analysis of 483 cases”. Diabetes
Metab Syndr, 14 (6), 2020, 2245-2249.
[4] Tong X, Cheng, et al., “Characteristics of
peripheral white blood cells in COVID-19
patients revealed by a retrospective cohort
study”. BMC Infect Dis, 21 (1), 2021, 1236.
[5] Naoum AF, Ruiz, et al., “Diagnostic and prognostic
utility of WBC counts and cell population data in
patients with COVID-19”. Int J Lab Hematol, 43
Suppl 1 (Suppl 1), 2021, 124-128.
[6] García-Cervera C, Giner-Galvañ et al.,
“Estimation of Admission D-dimer Cut-off
Value to Predict Venous Thrombotic Events in
Hospitalized COVID-19 Patients: Analysis of
the SEMI-COVID-19 Registry”; J Gen Intern
Med, 36 (11), 2021, 3478-3486.
[7] Ganesan R, Mahajan, et al., “Mortality Prediction
of COVID-19 Patients at Intensive Care Unit
Admission”. Cureus, 13 (11), 2021, e19690.
[8] Suastika WNK, “The Optimal Cutoff Value of
D-dimer Levels to Predict in Hospital Mortality in
Severe Cases of Coronavirus Disease 2019”. Open
Access Maced J Med Sci, 9, 2021, 1561-1564.
[9] Kim Y, Khose, et al., “Predicting In-hospital
Mortality Using D-Dimer in COVID-19 Patients
With Acute Ischemic Stroke”; Front Neurol, 12,
2021, 702927.
[10] Lauer AS, Grantz, et al., “The Incubation Period
of Coronavirus Disease 2019 (COVID-19) From
Publicly Reported Confirmed Cases: Estimation
and Application”. Ann Intern Med, 172 (9),
2020, 577-582.